Literature DB >> 17406108

Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population.

Agnieszka Slowik1, Dorota Wloch, Pawel Szermer, Pawel Wolkow, Maciej Malecki, Joanna Pera, Wojciech Turaj, Tomasz Dziedzic, Aleksandra Klimkowicz-Mrowiec, Grzegorz Kopec, Denise A Figlewicz, Andrzej Szczudlik.   

Abstract

BACKGROUND: Oxidative stress plays a role in atherosclerosis. Human paraoxonase (PON) gene products exhibit antioxidant properties. We studied the significance of the Q192R and M55L polymorphisms of the PON1 gene and the C311S polymorphism of the PON2 gene in different etiologies of ischemic stroke.
METHODS: One hundred and thirty-six patients with large vessel disease (LVD) stroke, 140 with small vessel disease stroke, 272 with cardioembolic stroke, and their age- and sex-matched controls were included. PON genotypes were evaluated by PCR-RFLP analyses.
RESULTS: The distribution of PON1 polymorphisms was similar in each stroke group and in the respective controls. Genotypes with the C allele of the PON2 gene C311S polymorphism were overrepresented in LVD stroke patients as compared with their controls, both in univariate and multivariate (dominant model: OR = 1.58, 95% CI: 1.006-2.48) analyses.
CONCLUSION: The genotype with the C allele of the PON2 gene is a risk factor for LVD stroke in a Polish population. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406108     DOI: 10.1159/000101462

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  14 in total

1.  Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.

Authors:  Indranil Banerjee
Journal:  Eur J Epidemiol       Date:  2010-06-09       Impact factor: 8.082

Review 2.  The paraoxonase gene family and atherosclerosis.

Authors:  David Seo; Pascal Goldschmidt-Clermont
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

3.  Association between PON1 L55M polymorphism and ischemic stroke: a systematic review and meta-analysis.

Authors:  Peng Shao; Da-Jun Qu; Rui-Ying Song; Ming-Lu Chen; Li-Hua Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects.

Authors:  Bing-Hu Li; Li-Li Zhang; Yan-Wei Yin; Yan Pi; Qing-Wu Yang; Chang-Yue Gao; Chuan-Qin Fang; Jing-Zhou Wang; Jing-Cheng Li
Journal:  Mol Biol Rep       Date:  2011-12-20       Impact factor: 2.316

5.  Drosophila are protected from Pseudomonas aeruginosa lethality by transgenic expression of paraoxonase-1.

Authors:  David A Stoltz; Egon A Ozer; Peter J Taft; Marilyn Barry; Lei Liu; Peter J Kiss; Thomas O Moninger; Matthew R Parsek; Joseph Zabner
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

6.  Association Between Paraoxonase Gene Polymorphisms and Intracerebral Hemorrhage in a Korean Population.

Authors:  Hae Jeong Park; Su Kang Kim; Hyun-Kyung Park; Joo-Ho Chung
Journal:  J Mol Neurosci       Date:  2015-07-31       Impact factor: 3.444

Review 7.  Genetics of atherothrombotic and lacunar stroke.

Authors:  Stéphanie Debette; Sudha Seshadri
Journal:  Circ Cardiovasc Genet       Date:  2009-04

Review 8.  Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.

Authors:  Issa J Dahabreh; Georgios D Kitsios; David M Kent; Thomas A Trikalinos
Journal:  Genet Med       Date:  2010-10       Impact factor: 8.822

9.  A common mutation in paraoxonase-2 results in impaired lactonase activity.

Authors:  David A Stoltz; Egon A Ozer; Thomas J Recker; Miriam Estin; Xia Yang; Diana M Shih; Aldons J Lusis; Joseph Zabner
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

10.  Paraoxonase gene polymorphism in south-western Korean population.

Authors:  Byoung-Soo Shin
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.